Making healthcare better is our priority, and we believe medical technology can play an even greater role in improving people’s lives. With challenges facing families and healthcare systems — such as rising costs, aging populations, and the burden of chronic disease — we are using the power of technology to take healthcare Further, Together.
Innovation and collaboration are central to who we are. Since the late 1940s, we have been working with others to alleviate pain, restore health, and extend life. Today, we are a medical technology leader, employing more than 84,000 people worldwide, and offering therapies and solutions that enable greater efficiency, access, and value — for healthcare systems, providers, and the people they serve.
Learn more at Medtronic.com.
Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care to patients. In fiscal 2020, which ended on September 30, 2020, Siemens Healthineers, which has approximately 54,000 employees worldwide, generated revenue of €14.5 billion and adjusted EBIT of €2.2 billion.
Further information is available at www.siemens-healthineers.com.
With Augmedics, the future of surgery is in sight. The Chicago-based company aims to improve healthcare by augmenting surgery with cutting edge technologies that solve unmet clinical needs and instill technological confidence in the surgical workflow. Its pioneering xvision system, the first augmented reality navigation technology to be used in surgery, allows surgeons to see the patient’s anatomy through skin and tissue as if they have “x-ray vision,” allowing them to more accurately navigate instruments and implants during procedures.
For more information, visit www.augmedics.com.
Augmedics’ groundbreaking xvision Spine system (XVS) is the first augmented reality (AR) navigation system to be used in surgery. xvision Spine allows surgeons to visualize their patients’ 3D spinal anatomy during surgery as if they had “x-ray vision,” helping them to accurately navigate instruments and implants while looking directly at the patient, rather than a remote screen. The XVS consists of a transparent near-eye-display headset and all elements of a traditional navigation system. It accurately determines the position of surgical tools, in real-time, and superimposes them on the patient's CT data. The navigation data is then projected onto the surgeon’s retina using the headset, allowing him or her to simultaneously look at the patient and see the navigation data without averting their eyes to a remote screen during the procedure. The system is designed to revolutionize how surgery is done by giving the surgeon better control and visualization, which may lead to easier, faster and safer surgeries.
Proven Product Solutions for over 30 Years
Centinel Spine is the largest privately-held spine company focused on anterior column reconstruction. The company offers a continuum of trusted, brand-name motion-preserving and fusion solutions backed by over 30 years of clinical success — providing the most robust and clinically-proven Total Disc Replacement and Integrated Interbody™ portfolios in the world.
For more information prior to GSC 2021, please visit the company’s website below or contact: email@example.com
Cerapedics is an advanced orthobiologics company focused on developing its proprietary biomimetic small peptide molecule (P-15) for commercialization in spinal applications. Among 400+ spinal bone grafts on the market, spine surgeons can feel confident in choosing i-FACTOR Peptide Enhanced Bone Graft as it is one of only two FDA PMA Approved bone grafts on the market, and it has shown statistical superiority to local autograft through an IDE trial on single-level ACDFs in overall clinical success at one year and maintained at two years.
i-FACTOR® is the only biologic bone graft in orthopedics that incorporates a small peptide as an attachment factor to stimulate the natural bone healing process. This novel mechanism of action (Attract, Attach, Activate) is designed to support safer and more predictable bone formation compared to other commercially available bone growth factors.
i-FACTOR is free of many safety risks seen with other products such as ectopic bone formation and on average costs at least 30% less expensive than other drug-device combination products.
With patient well-being as a priority, Cousin biotech, a French manufacturing company, conceptualizes, ensure global regulatory compliance, manufactures and commercializes implantable medical devices for Spine, Orthopaedics and Visceral surgeries.
Throughout industrial and scientific collaborations, we imagine and materialize innovative surgical solutions to provide surgeons with additional techniques that fit all their patients’ pathologies and conditions.
Thanks to IntraSPINE and B-DYN, our spine portfolio makes dynamic stabilization and motion preservation efficient and globally recognized alternatives to fusion surgeries.
With our sublaminar bands and groundbreaking single-use ancillaries, we bring surgeons worldwide safe and efficient tools to treat spinal correction and deformity.
Visit us in our booth during 2021 GSC event!
All our commercial and technical teams will be thrilled to present our technologies and share their experience and expertise with all of you.
Globus Medical, a leading musculoskeletal solutions company is driving significant technological advancements across a complete suite of products ranging from spinal, trauma and orthopedics therapies to robotics, navigation and imaging. Founded in 2003, Globus’ single-minded focus on advancing spinal surgery has made it the fastest growing company in the history of orthopedics. Globus is driven to utilize superior engineering and technology to achieve pain free, active lives for all patients with musculoskeletal disorders.
icotec, a Swiss company, designs and manufactures non-metallic spinal implants made from carbon fibre reinforced PEEK (Carbon/PEEK). Carbon/PEEK breaks barriers in radiotherapy: it enables artifact-free CT/MRI images for accurate delineation of critical structures and accelerated dose planning. During radiotherapy, Carbon PEEK is radiolucent, enables homogenous doses and avoids shielding and scattering. Radiation therapy during tumor treatment is no longer limited by metallic implants.
Spineway is a French company dedicated to providing spine surgery solutions with the aim of improving patient’s quality of life and surgeon’s experience. Since its creation in 2005, Spineway developed its sales network and is now distributed in more than 35 countries, becoming a significant player in the spine sector.
Based on the comprehension of surgeon and medical staff needs, spine surgery evolutions and technical improvement, our range of arthrodesis systems for adult and pediatric permits to cover the majority of spine indications.
Committed to continuous improvement, we completed our offer with a new modular platform that permits to treat a wide range of indications, through all standard surgical approach, with one unique implant range.